PR

Active Director Designated Partner DIN 10817375
DIN 10817375 First appointment Oct 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Payal Raj

Data last updated:

Payal Raj is a Designated Partner at Medima Pharmaceuticals Llp (since 2024). The company operates in Pharma.

DIN 10817375
Primary Designation Designated Partner
Industry Pharma
First Appointment 22 Oct 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner22 Oct 20242024Active

Board colleagues of Payal Raj

NameDINCompanyDesignation
Kailash11307258Medima Pharmaceuticals LlpDesignated Partner
Pooja Raj10817374Medima Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Medima Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Payal Raj

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Payal Raj

Payal Raj currently holds 1 directorship: Medima Pharmaceuticals Llp (Designated Partner, since 22 Oct 2024).

Payal Raj was first appointed on 22 Oct 2024 as Designated Partner at Medima Pharmaceuticals Llp.

The current boards of Payal Raj's companies include Kailash (Medima Pharmaceuticals Llp), Pooja Raj (Medima Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available